rHIgM22

rHIgM22 · Acorda Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rHIgM22, covering 2015-02-27 to 2015-02-27. Get the full timeline:

Most recent: Clinical Trial Update: An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis [Phase 1]